LAURA MEDINA RODRÍGUEZ – ENSAYO CLINICO COMERCIAL – BOSTON PHARMACEUTICALS
A Phase 1 Study of BOS172738 in Patients with Advanced Solid Tumors with RET Gene Alterations including Non Small Cell Lung Cancer (NSCLC) and Medullary Thyroid Cancer (MTC)
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - CIMO-01 | 0 comments